CorMedix Inc.  

(Public, NYSEMKT:CRMD)   Watch this stock  
Find more results for CRMD
1.85
0.00 (0.00%)
Oct 23 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range     -
52 week 0.66 - 3.20
Open     -
Vol / Avg. 0.00/67,416.00
Mkt cap 40.70M
P/E     -
Div/yield     -
EPS -1.12
Shares 22.00M
Beta -0.78
Inst. own 16%
Sep 3, 2014
CorMedix Inc at FBR & Co Inaugural Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 8832.85% -456655.00%
Operating margin -4756.41% -318753.00%
EBITD margin - -245512.00%
Return on average assets 156.25% -443.24%
Return on average equity - -
Employees 2 -
CDP Score - -

Address

Suite 303, 745 Route 202-206
BRIDGEWATER, NJ 08807
United States - Map
+1-908-5179500 (Phone)
+1-908-4294307 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

CorMedix Inc. (CorMedix) is a biopharmaceutical company that focuses on in-licensing, developing and commercializing therapeutic products for the treatment of cardiac and renal dysfunction, also know as Cardiorenal disease. The Company has licensed all of the products in its Cardiorenal pipeline. The Company has several product candidates in clinical development, including its product candidates, CRMX003 (CorMedix Neutrolin), a liquid designed to prevent central venous catheter infection and clotting initially in dialysis catheters, and CRMX001 (the Company�s formulation of the drug deferiprone), which targets the prevention of contrast-induced nephropathy in patients.

Officers and directors

Randy Milby Chief Executive Officer, Director
Age: 61
Bio & Compensation  - Reuters
Antony E. Pfaffle M.D. Vice Chairman of the Board, Chief Scientific Officer
Age: 50
Bio & Compensation  - Reuters
Harry O'Grady Chief Financial Officer
Bio & Compensation  - Reuters
Matthew P. Duffy Independent Director
Age: 51
Bio & Compensation  - Reuters
Michael W. George Independent Director
Age: 65
Bio & Compensation  - Reuters
Steven W. Lefkowitz Independent Director
Age: 58
Bio & Compensation  - Reuters
Taunia S. Markvicka Pharm.D. Independent Director
Age: 45
Bio & Compensation  - Reuters
Cora M. Tellez Independent Director
Bio & Compensation  - Reuters